Imatinib Completed Phase 1 Trials for Thymic Carcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00314873Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma